 RADNOR, Pa., April 19, 2021 PRNewswire -- The issues raised by Relief Therapeutics in its release dated April 19, 2021 have no bearing on NeuroRxs ability or commitment to deliver a safe, effective, and stable lifesaving drug on a worldwide basis. 